Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
Paul Kellam, William Barclay
Journal of General Virology (2020) Vol. 101, Iss. 8, pp. 791-797
Open Access | Times Cited: 367

Showing 26-50 of 367 citing articles:

S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters
Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, et al.
Science Translational Medicine (2022) Vol. 15, Iss. 679
Open Access | Times Cited: 76
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
Spyros Chalkias, Jordan L. Whatley, Frank Eder, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2325-2333
Open Access | Times Cited: 44
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 130
Comparison of Four SARS-CoV-2 Neutralization Assays
Lydia Riepler, Annika Rössler, Albert Falch, et al.
Vaccines (2020) Vol. 9, Iss. 1, pp. 13-13
Open Access | Times Cited: 123
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
Jorge Carrillo, Nuria Izquierdo‐Useros, Carlos Ávila‐Nieto, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 187-191
Open Access | Times Cited: 114
Inversion of a SIR-based model: A critical analysis about the application to COVID-19 epidemic
Alessandro Comunian, Romina Gaburro, M. Giudici
Physica D Nonlinear Phenomena (2020) Vol. 413, pp. 132674-132674
Open Access | Times Cited: 100
COVID-19: A challenge for electrochemical biosensors
Jiří Kudr, Petr Michálek, Lada Ilieva, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 136, pp. 116192-116192
Open Access | Times Cited: 99
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Laith J. Abu‐Raddad, Hiam Chemaitelly, Joel A. Malek, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 98
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics
Konstantin Chumakov, Michael S. Avidan, Christine Stabell Benn, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 21
Open Access | Times Cited: 86
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Tiandan Xiang, Boyun Liang, Yaohui Fang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 85
Modeling the second wave of COVID-19 infections in France and Italy via a stochastic SEIR model
Davide Faranda, Tommaso Alberti
Chaos An Interdisciplinary Journal of Nonlinear Science (2020) Vol. 30, Iss. 11
Open Access | Times Cited: 84
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
Craig Thompson, Nicholas E. Grayson, Robert S. Paton, et al.
Eurosurveillance (2020) Vol. 25, Iss. 42
Open Access | Times Cited: 83
Antibody response to SARS-CoV-2 infection in humans: a systematic review
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 83
Reinfection risk of novel coronavirus (CoVID-19): A systematic ‎review of current evidence
SeyedAhmad SeyedAlinaghi, Shahram Oliaei, Shaghayegh Kianzad, et al.
World Journal of Virology (2020) Vol. 9, Iss. 5, pp. 79-90
Open Access | Times Cited: 83
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 82
Peridomestic Mammal Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Angela M. Bosco‐Lauth, J. Jeffrey Root, Stephanie Porter, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 8, pp. 2073-2080
Open Access | Times Cited: 80
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Chuan-Tien Hung, et al.
mBio (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 79
SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia
Ritu Mishra, Akhil C. Banerjea
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 78
SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons
Nele Wellinghausen, Dietmar Plonné, Meike Voss, et al.
Journal of Clinical Virology (2020) Vol. 130, pp. 104542-104542
Open Access | Times Cited: 76
Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
Frauke Muecksch, Helen Wise, Becky Batchelor, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 76
SIRSi compartmental model for COVID-19 pandemic with immunity loss
Cristiane M. Batistela, Diego Paolo Ferruzzo Correa, Átila Madureira Bueno, et al.
Chaos Solitons & Fractals (2020) Vol. 142, pp. 110388-110388
Open Access | Times Cited: 76
SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
Paul Van Caeseele, Dana Bailey, Sarah Forgie, et al.
Canadian Medical Association Journal (2020) Vol. 192, Iss. 34, pp. E973-E979
Open Access | Times Cited: 74
Point of Care Sensors for Infectious Pathogens
Mohamed Sharafeldin, Jason J. Davis
Analytical Chemistry (2020) Vol. 93, Iss. 1, pp. 184-197
Closed Access | Times Cited: 74
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
Robert Parker, Thomas Partridge, Catherine Wormald, et al.
Cell Reports (2021) Vol. 35, Iss. 8, pp. 109179-109179
Open Access | Times Cited: 73

Scroll to top